Interim Phase 3 analysis of the Oxford / AstraZeneca Covid-19 vaccine candidate showed a 70.4 percent efficacy in preventing the disease, Oxford University announced on Monday. At two different dosing regimens, the vaccine, AZD1222, was 90% and 62% effective. In the most effective dosing regimen, AZD1222 was administered as a …
Read More »WHO sweetens deal for richest nations to join global plan to counter ‘vaccine nationalism’
The Director General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, leaves a press conference organized by the United Nations Correspondents Association in Geneva (ACANU) amid the COVID-19 outbreak, caused by the new coronavirus, at WHO headquarters in Geneva, Switzerland, on July 3. 2020. Fabrice Coffrini / Pool via …
Read More »